Cue Biopharma Inc

NASDAQ:CUE   2:45:13 PM EDT
12.20
+0.09 (+0.74%)
Earnings Announcements

Cue Biopharma Inc Posts Qtrly Collaboration Revenue $2.7 Million Versus $1.1 Million

Published: 08/17/2021 20:51 GMT
Cue Biopharma Inc (CUE) - Cue Biopharma Reports Second Quarter 2021 Results, Recent Data Updates of Cue-101 Phase 1 Dose Escalation and Expansion Study, Platform Progress and Business Highlights.
Cue Biopharma Inc Qtrly Net Loss per Common Share $ 0.33.
Cue Biopharma Inc Qtrly Collaboration Revenue $2.7 Million Versus $1.1 Million.
Revenue is expected to be $2.29 Million
Adjusted EPS is expected to be -$0.37

Next Quarter Revenue Guidance is expected to be $4.28 Million
Next Quarter EPS Guidance is expected to be -$0.30

More details on our Analysts Page.